IFRS 9 for Pharmaceuticals & Life Sciences
What IFRS 9 means for Pharmaceuticals & Life Sciences organizations — and how we implement it at the architecture level.
IFRS 9 in Pharmaceuticals & Life Sciences environments carries requirements that go beyond the framework's general provisions. The specific operations of Pharmaceuticals & Life Sciences organizations — their data processing scale, their regulatory relationships, and their operational dependencies — create compliance obligations that engineering teams must address at the architecture level. Generic IFRS 9 compliance that ignores the Pharmaceuticals & Life Sciences context will produce a system that passes audit by a framework-generalist but fails review by an industry-specialist examiner.
Our teams deploy in Pharmaceuticals & Life Sciences environments with IFRS 9 compliance built into the architecture from the first design decision. The compliance controls are not a layer added to an existing system — they are implemented as first-class components that generate evidence continuously as the system operates. The result is a system that is compliant on deployment day, remains compliant as it evolves, and produces audit evidence without manual assembly.
IFRS 9 compliance documentation maintained as live system artifacts, not annual documentation projects
Access controls that satisfy IFRS 9 requirements for Pharmaceuticals & Life Sciences data handling
Audit logging that generates evidence meeting IFRS 9 audit standards in Pharmaceuticals & Life Sciences regulatory contexts
Incident response procedures aligned to IFRS 9 notification and reporting timelines
Third-party vendor compliance documentation satisfying IFRS 9 supply chain requirements
We implement IFRS 9 compliance for Pharmaceuticals & Life Sciences clients by mapping the framework's requirements to the specific operational context of Pharmaceuticals & Life Sciences organizations before writing application code. Controls are implemented through infrastructure-as-code, enforced automatically by ALICE at every commit, and documented through automated evidence generation pipelines. The result is a IFRS 9-compliant Pharmaceuticals & Life Sciences system delivered on a fixed-price timeline.
Ready to build IFRS 9 compliance into your Pharmaceuticals & Life Sciences system?
We build compliance architecture for Pharmaceuticals & Life Sciences organizations — IFRS 9 and the full Pharmaceuticals & Life Sciences compliance landscape — from the first infrastructure decision. Fixed price. Production delivery. No discovery phase.